| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 265 | 1,059 | 933 | | Cost of Revenue | 798 | 930 | 1,275 | | | Gross Profit | (533) | 129 | (342) | | | Operating Expenses | | Research Development | 5,800 | 10,444 | 10,127 | | Selling General and Administrative | 6,478 | 8,974 | 8,225 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (12,811) | (19,289) | (18,694) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 592 | 1,266 | (59) | | Earnings Before Interest And Taxes | (12,219) | (18,023) | (18,753) | | Interest Expense |
-
| 116 | 646 | | Income Before Tax | (12,219) | (18,139) | (19,399) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (12,219) | (18,139) | (19,399) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (12,219) | (18,139) | (19,399) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,219) | ($18,139) | ($19,399) |
|
0.29% Nasdaq 
Income Statement
